FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3089593691> ?p ?o ?g. }

• W3089593691 endingPage "399" @default.
• W3089593691 startingPage "390" @default.
• W3089593691 abstract "Abstract Background Black race is associated with worse outcomes in early breast cancer. We evaluated clinicopathologic characteristics, the 21-gene recurrence score (RS), treatment delivered, and clinical outcomes by race and ethnicity among women who participated in the Trial Assigning Individualized Options for Treatment. Methods The association between clinical outcomes and race (White, Black, Asian, other or unknown) and ethnicity (Hispanic vs non-Hispanic) was examined using proportional hazards models. All P values are 2-sided. Results Of 9719 eligible women with hormone receptor–positive, HER2-negative, node-negative breast cancer, there were 8189 (84.3%) Whites, 693 (7.1%) Blacks, 405 (4.2%) Asians, and 432 (4.4%) with other or unknown race. Regarding ethnicity, 889 (9.1%) were Hispanic. There were no substantial differences in RS or ESR1, PGR, or HER2 RNA expression by race or ethnicity. After adjustment for other covariates, compared with White race, Black race was associated with higher distant recurrence rates (hazard ratio [HR] = 1.60, 95% confidence intervals [CI] = 1.07 to 2.41) and worse overall survival in the RS 11-25 cohort (HR = 1.51, 95% CI = 1.06 to 2.15) and entire population (HR = 1.41, 95% CI = 1.05 to 1.90). Hispanic ethnicity and Asian race were associated with better outcomes. There was no evidence of chemotherapy benefit for any racial or ethnic group in those with a RS of 11-25. Conclusions Black women had worse clinical outcomes despite similar 21-gene assay RS results and comparable systemic therapy in the Trial Assigning Individualized Options for Treatment. Similar to Whites, Black women did not benefit from adjuvant chemotherapy if the 21-gene RS was 11-25. Further research is required to elucidate the basis for this racial disparity in prognosis." @default.
• W3089593691 created "2020-10-08" @default.
• W3089593691 creator A5003724529 @default.
• W3089593691 creator A5006346528 @default.
• W3089593691 creator A5008665323 @default.
• W3089593691 creator A5013631740 @default.
• W3089593691 creator A5016973435 @default.
• W3089593691 creator A5023518588 @default.
• W3089593691 creator A5027918729 @default.
• W3089593691 creator A5044108002 @default.
• W3089593691 creator A5044222771 @default.
• W3089593691 creator A5044773708 @default.
• W3089593691 creator A5047918797 @default.
• W3089593691 creator A5049425361 @default.
• W3089593691 creator A5057135409 @default.
• W3089593691 creator A5057199961 @default.
• W3089593691 creator A5057255241 @default.
• W3089593691 creator A5058313869 @default.
• W3089593691 creator A5059538753 @default.
• W3089593691 creator A5063504632 @default.
• W3089593691 creator A5066769011 @default.
• W3089593691 creator A5069182089 @default.
• W3089593691 creator A5069524701 @default.
• W3089593691 creator A5069748055 @default.
• W3089593691 creator A5072416022 @default.
• W3089593691 creator A5078129443 @default.
• W3089593691 creator A5079064611 @default.
• W3089593691 creator A5082799664 @default.
• W3089593691 creator A5085875361 @default.
• W3089593691 creator A5090508016 @default.
• W3089593691 date "2020-09-28" @default.
• W3089593691 modified "2023-10-15" @default.
• W3089593691 title "Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial" @default.
• W3089593691 cites W1830454849 @default.
• W3089593691 cites W1996337195 @default.
• W3089593691 cites W2016725888 @default.
• W3089593691 cites W2046288414 @default.
• W3089593691 cites W2067707819 @default.
• W3089593691 cites W2079924572 @default.
• W3089593691 cites W2096864872 @default.
• W3089593691 cites W2096910968 @default.
• W3089593691 cites W2098203737 @default.
• W3089593691 cites W2105882193 @default.
• W3089593691 cites W2109584286 @default.
• W3089593691 cites W2112562332 @default.
• W3089593691 cites W2122433511 @default.
• W3089593691 cites W2135685074 @default.
• W3089593691 cites W2149630607 @default.
• W3089593691 cites W2160786885 @default.
• W3089593691 cites W2161426850 @default.
• W3089593691 cites W2166647521 @default.
• W3089593691 cites W2239972055 @default.
• W3089593691 cites W2240411731 @default.
• W3089593691 cites W2247128519 @default.
• W3089593691 cites W2567001274 @default.
• W3089593691 cites W2750506302 @default.
• W3089593691 cites W2805734855 @default.
• W3089593691 doi "https://doi.org/10.1093/jnci/djaa148" @default.
• W3089593691 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8599918" @default.
• W3089593691 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32986828" @default.
• W3089593691 hasPublicationYear "2020" @default.
• W3089593691 type Work @default.
• W3089593691 sameAs 3089593691 @default.
• W3089593691 citedByCount "48" @default.
• W3089593691 countsByYear W30895936912021 @default.
• W3089593691 countsByYear W30895936912022 @default.
• W3089593691 countsByYear W30895936912023 @default.
• W3089593691 crossrefType "journal-article" @default.
• W3089593691 hasAuthorship W3089593691A5003724529 @default.
• W3089593691 hasAuthorship W3089593691A5006346528 @default.
• W3089593691 hasAuthorship W3089593691A5008665323 @default.
• W3089593691 hasAuthorship W3089593691A5013631740 @default.
• W3089593691 hasAuthorship W3089593691A5016973435 @default.
• W3089593691 hasAuthorship W3089593691A5023518588 @default.
• W3089593691 hasAuthorship W3089593691A5027918729 @default.
• W3089593691 hasAuthorship W3089593691A5044108002 @default.
• W3089593691 hasAuthorship W3089593691A5044222771 @default.
• W3089593691 hasAuthorship W3089593691A5044773708 @default.
• W3089593691 hasAuthorship W3089593691A5047918797 @default.
• W3089593691 hasAuthorship W3089593691A5049425361 @default.
• W3089593691 hasAuthorship W3089593691A5057135409 @default.
• W3089593691 hasAuthorship W3089593691A5057199961 @default.
• W3089593691 hasAuthorship W3089593691A5057255241 @default.
• W3089593691 hasAuthorship W3089593691A5058313869 @default.
• W3089593691 hasAuthorship W3089593691A5059538753 @default.
• W3089593691 hasAuthorship W3089593691A5063504632 @default.
• W3089593691 hasAuthorship W3089593691A5066769011 @default.
• W3089593691 hasAuthorship W3089593691A5069182089 @default.
• W3089593691 hasAuthorship W3089593691A5069524701 @default.
• W3089593691 hasAuthorship W3089593691A5069748055 @default.
• W3089593691 hasAuthorship W3089593691A5072416022 @default.
• W3089593691 hasAuthorship W3089593691A5078129443 @default.
• W3089593691 hasAuthorship W3089593691A5079064611 @default.
• W3089593691 hasAuthorship W3089593691A5082799664 @default.
• W3089593691 hasAuthorship W3089593691A5085875361 @default.
• W3089593691 hasAuthorship W3089593691A5090508016 @default.
• W3089593691 hasBestOaLocation W30895936912 @default.
• W3089593691 hasConcept C121608353 @default.

• next